INVACARE CORPORATION (NYSE:IVC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On September 18, 2019, the Board of Directors of Invacare Corporation (the “Company”) appointed Julie Beck as a director of the Company on the unanimous recommendation of the Nominating and Governance Committee. Ms. Beck has been appointed to serve a term expiring at the Company’s 2020 Annual Meeting of Shareholders.

Ms. Beck has more than 30 years of experience in the manufacturing, industrial and consumer industries, and is a certified public accountant. Ms. Beck was unanimously appointed by the current members of the Board after an extensive search conducted by an internationally recognized executive search firm. She will serve as a member of the company’s Audit Committee and its Nominating and Governance Committee. Her appointment brings the number of Invacare directors to a total of nine, eight of whom are considered independent directors.

There is no arrangement or understanding between Ms. Beck and any other person to which Ms. Beck was elected as a director of the Company. Ms. Beck has not entered into any related party transactions with the Company that are required to be disclosed to Item 404(a) of Regulation S-K.

As a director, Ms. Beck will participate in the Company’s current program for the compensation of non-employee directors, which is described under the caption “Director Compensation Program” in the Company’s Definitive Proxy Statement on Schedule 14A filed with Securities and Exchange Commission on April 12, 2019. In accordance with the director compensation program, Ms. Beck is expected to receive a grant of 9,023 restricted stock units under the Company’s 2018 Equity Compensation Plan.

On September 18, 2019, the Company issued a press release announcing the appointment of Ms. Beck to the Board of Directors, which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

INVACARE CORP Exhibit
EX-99.1 2 sep2019exhibit.htm EXHIBIT 99.1 Exhibit Exhibit 99.1NEWS RELEASECONTACT:Lois Lee  loislee@invacare.com  440-329-6435INVACARE CORPORATION APPOINTS JULIE BECK TO BOARD OF DIRECTORSELYRIA,…
To view the full exhibit click here

About INVACARE CORPORATION (NYSE:IVC)

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.